Lv689
2890 积分 2021-09-07 加入
Discovery of novel antibody-drug conjugates bearing tissue protease specific linker with both anti-angiogenic and strong cytotoxic effects
2天前
已完结
From bench to bedside: the past, present and future of IL-21 immunotherapy
3天前
已完结
Biological effects of IL-21 on immune cells and its potential for cancer treatment
3天前
已完结
Implications of IL-21 in solid tumor therapy
3天前
已完结
The pros and confs of IL-18 activation
3天前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
3天前
已完结
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
3天前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
3天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
4天前
已完结
CDRxAbs: Antibody Small-Molecule Conjugates with Computationally Designed Target-Binding Synergy
6天前
已完结
皖公网安备34019202002308
